Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer

By afschroeder • October 14, 2025

Chan AA, Sankar K, Reckamp KL, Díaz B, Lee DJ. Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer. Sci Rep. 2025 Oct 13;15(1):35597. doi: 10.1038/s41598-025-11897-9. PMID: 41083501.

Tags: Cedars Sinai DoM, Dermatology, Harbor UCLA, Hematology/Oncology, Lung adenocarcinoma, NMT1, Publications, survival, The Cancer Genome Atlas, TIMM17A

Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery

Shimoda TM, Miyamoto Y, Ueyama HA, Itagaki S, Kaneko T, Gotanda H, Inoue K, Fukuhara S, Ailawadi G, Takayama H, Kuno T, Tsugawa Y. Comparison[...]

A Porcine Model of Intervertebral Disc Injury Recapitulates Human Discogenic Pain Via Notochordal Cell Loss and Pain-Inducing Nucleus Pulposus Cell Emergence

Kaneda G, Wechsler JT, Chavez M, Sheyn J, Cheema K, Shen C, Rigo De Righi D, Wang L, Hsu YC, Avalos P, Xie Y, Tawackoli[...]

Integrating Natural Language Processing With ChatGPT to Improve Quality of Artificial Intelligence Summaries of Prostate Cancer Consultations

Friedrich NA, Das SK, Luu M, Daniels JP, Heard J, Barsegyan A, Freedland SJ, Spiegel B, Kokorowski PK, Gonzalez Hernandez G, Daskivich TJ. Integrating Natural[...]